Next Article in Journal
Feature Reviews in Pharmaceutical Technology
Next Article in Special Issue
Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies
Previous Article in Journal
Evaluation of Ayush-64 (a Polyherbal Formulation) and Its Ingredients in the Syrian Hamster Model for SARS-CoV-2 Infection Reveals the Preventative Potential of Alstonia scholaris
Previous Article in Special Issue
An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 16
Issue 9
10.3390/ph16091335
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Bibliometric Review on New Possibilities of Antimycobacterial Agents: Exploring Siderophore Desferrioxamine’s Applications as an Antimicrobial Agent

by
Patrícia Vieira de Oliveira
1,
Roseane Lustosa de Santana Lira
2,
Rafael de Abreu Lima
2,
Yasmim Costa Mendes
1,
Antenor Bezerra Martins
3,
Bruna de Oliveira de Melo
4,
Millena Ferreira Goiano
5,
Rivaldo Lira Filho
6,
Flávia Baluz Bezerra de Farias Nunes
7,
Amanda Silva dos Santos Aliança
1,3,
Wellyson da Cunha Araújo Firmo
1,3,
Rafael Cardoso Carvalho
2,
Adrielle Zagmignan
1,3 and
Eduardo Martins de Sousa
1,2,3,4,*
1
Graduate Program in Microbial Biology, CEUMA University—UNICEUMA, São Luís 65075-120, Brazil
2
Graduate Program in Health Sciences, Federal University of Maranhão—UFMA, São Luís 65080-805, Brazil
3
Graduate Program in Health and Services Management, CEUMA University—UNICEUMA, São Luís 65075-120, Brazil
4
Graduate Program in Biodiversity and Biotechnology—BIONORTE Amazonian Network, Federal University of Maranhão—UFMA, São Luís 65080-805, Brazil
5
Graduate Program in Biomedicine, CEUMA University—UNICEUMA, São Luís 65075-120, Brazil
6
Graduate Program in Nursing, St. Therese College—CEST, São Luís 65045-180, Brazil
7
Graduate Program in Nursing, Federal University of Maranhão—UFMA, São Luís 65080-805, Brazil
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2023, 16(9), 1335; https://doi.org/10.3390/ph16091335
Submission received: 1 August 2023 / Revised: 7 September 2023 / Accepted: 16 September 2023 / Published: 21 September 2023
(This article belongs to the Special Issue Novel Insights into Tuberculosis Research and Drug Discovery)
Browse Figures
Versions Notes

Abstract

Mycobacteria cause tuberculosis and other serious diseases. Understanding their mechanisms of resistance to our immune system and exploring novel drugs are critical strategies to combat infections. A bibliometric analysis was performed to identify publication trends and critical research areas in the field of the antimicrobial activity of desferrioxamine. A total of twenty-four publications on the topic, from 2012 to 2023, were retrieved from databases including Web of Science, Scopus, PubMed, and Embase, using specific keywords. The quality of the publications was assessed using impact and productivity metrics, with an average annual publication rate of 2.1 articles. The United States emerged as the most productive country, with medicine (23.4%, 11 publications) and biochemistry, genetics, and molecular biology (21.3%, 10 publications) as the top research fields. The five most cited publications accounted for 672 citations, with a relatively low h-index (11:11). In conclusion, there has been a lack of publications on this topic in the last decade. The United States dominates production and publication in this area, and there appears to be limited exchange of knowledge, ideas, and technology within the field. Therefore, fostering international cooperation through funding is essential to facilitate further research and development of desferrioxamine-related studies.
Keywords: siderophore; desferrioxamine; anti-infective agents; Mycobacterium siderophore; desferrioxamine; anti-infective agents; Mycobacterium

Share and Cite

MDPI and ACS Style

de Oliveira, P.V.; de Santana Lira, R.L.; de Abreu Lima, R.; Mendes, Y.C.; Martins, A.B.; de Melo, B.d.O.; Goiano, M.F.; Filho, R.L.; de Farias Nunes, F.B.B.; Aliança, A.S.d.S.; et al. Bibliometric Review on New Possibilities of Antimycobacterial Agents: Exploring Siderophore Desferrioxamine’s Applications as an Antimicrobial Agent. Pharmaceuticals 2023, 16, 1335. https://doi.org/10.3390/ph16091335

AMA Style

de Oliveira PV, de Santana Lira RL, de Abreu Lima R, Mendes YC, Martins AB, de Melo BdO, Goiano MF, Filho RL, de Farias Nunes FBB, Aliança ASdS, et al. Bibliometric Review on New Possibilities of Antimycobacterial Agents: Exploring Siderophore Desferrioxamine’s Applications as an Antimicrobial Agent. Pharmaceuticals. 2023; 16(9):1335. https://doi.org/10.3390/ph16091335

Chicago/Turabian Style

de Oliveira, Patrícia Vieira, Roseane Lustosa de Santana Lira, Rafael de Abreu Lima, Yasmim Costa Mendes, Antenor Bezerra Martins, Bruna de Oliveira de Melo, Millena Ferreira Goiano, Rivaldo Lira Filho, Flávia Baluz Bezerra de Farias Nunes, Amanda Silva dos Santos Aliança, and et al. 2023. "Bibliometric Review on New Possibilities of Antimycobacterial Agents: Exploring Siderophore Desferrioxamine’s Applications as an Antimicrobial Agent" Pharmaceuticals 16, no. 9: 1335. https://doi.org/10.3390/ph16091335

APA Style

de Oliveira, P. V., de Santana Lira, R. L., de Abreu Lima, R., Mendes, Y. C., Martins, A. B., de Melo, B. d. O., Goiano, M. F., Filho, R. L., de Farias Nunes, F. B. B., Aliança, A. S. d. S., Firmo, W. d. C. A., Carvalho, R. C., Zagmignan, A., & de Sousa, E. M. (2023). Bibliometric Review on New Possibilities of Antimycobacterial Agents: Exploring Siderophore Desferrioxamine’s Applications as an Antimicrobial Agent. Pharmaceuticals, 16(9), 1335. https://doi.org/10.3390/ph16091335

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop